Speculative M&A Transaction Analysis, page-714

I would not worry about it, I am sure BP also employs some very clever people who are on the top of their game. The main thing will be that these people would get the information and the validated clinical result, then I am sure that decision maker (with the money) can run the ruler over how much it worth for them. I just hope we will be in a very strong position (with lots of data) to negotiate the best possible deal for the shareholders. The numbers are beyond belief just on what we think it can do and am very sure still lots of additional use (especially the FTO area) which if properly explored will make RC220 (and followers) one of the wonder drugs. My head is still spinning - based on my very limited medical understanding - of how great drug it is for many applications and be able to help lots of people who are suffering from various diseases, not only cancer.